India to Poland: Regorafenib Export Trade Route

The India to Poland Regorafenib corridor is one of India's established pharmaceutical export routes, with 15 shipments documented worth a combined $8.8K USD. The route is dominated by LEOWIN HEALTHCARE LLP, which alone accounts for roughly 40% of all export value, reflecting the consolidated nature of India's regorafenib manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $588 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with regorafenib's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 12.6%, placing it at rank #17 among India's top regorafenib export destinations globally.

On the import side, key buyers of Indian regorafenib in Poland include PEKAO-CARGO SPOLKA Z O.O , TO THE ORDER.., TO THE ORDER and 5 others. PEKAO-CARGO SPOLKA Z O.O is the single largest importer with 2 shipments valued at $2.8K USD.

India's regorafenib exports to Poland are driven primarily by a handful of large-scale manufacturers. LEOWIN HEALTHCARE LLP with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — LEOWIN HEALTHCARE LLP, VINAYAK ASSOCIATES , SACRED LEAVES PRIVATE LIMITED — together account for 84% of total trade value on this route. The average shipment value of $588 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as regonat 40mg (regorafenib) batch: 702683 and regorafenib (regonat) batch: 702683 / ex , suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PEKAO-CARGO SPOLKA Z O.O is the largest importer with 2 shipments worth $2.8K USD — representing 32% of all regorafenib imports from India on this route. A total of 8 buyers are active on this corridor.